Remedium Lifecare Share Price

CMP as on29-Jul-21 15:27

₹ 134.70
1.8 1.35%

Open

₹ 136.80

Turnover (lac)

₹ 3

Prev. Close

₹ 132.90

Day's Vol (shares)

₹ 872

Day's Range

₹ 129.00
₹ 136.80

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 01-Jul-2021 - -
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/07/2021 ,inter alia, to consider and approve the Unaudited Standalone Financial Results for the quarter ended June 30, 2021 Outcome of the board meeting held on 07.07.2021 (As Per BSE Announcement Dated on 07.07.2021)
Board Meeting - 17-May-2021 - -
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2021 ,inter alia, to consider and approve 1. appointment of Mr. Vilas Lokhande (DIN: 01228041) as a Whole Time Director of the Company for a period of 3 years w.e.f. 20.05.2021 subject to the approval of the shareholders at the ensuing Annual General Meeting of the company. 2.and take on record the resignation of Mr. Siddharth Shah (DIN: 01343122) from the position of the Managing Director of the Company. 3. the raising of funds by issue of shares on a preferential basis or by way of qualified institutions placement up to INR 100 crores. 4.Any other matter with the permission of the chair. Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Resignation of Managing Director Outcome of the Board Meeting held on 20.05.2021 (As Per BSE Announcement dated on 20.05.2021)
Board Meeting - 04-May-2021 - -
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2021 ,inter alia, to consider and approve 1. the Audited Standalone Financial Results for the quarter and year ended March 31, 2021. 2. the shifting of the registered office of the company within the limits of same city of Mumbai. 3. Any other matter with the permission of the chair. Outcome of the Board Meeting held on 11.05.2021 (As Per BSE Announcement dated on 11.05.2021) We wish to inform you that the board of directors of the company at its meeting held on 11.05.2021, has approved shifting of the registered office of the company from existing office situated at 416D, 4th Floor, Dattani Plaza, Safed Pool, Sakinaka, Andheri (E), Mumbai - 400 072 to Office No. 601, Hyde Park, Saki Vihar Road, Andheri (E), Mumbai - 400072. (As Per BSE announcement Dated 12.05.2021)
Board Meeting - 03-Feb-2021 - -
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve the Unaudited Financial Results for the 3rd quarter and nine months ended 31st December, 2020 Outcome of the Board Meeting held on 12.02.2021 (As Per BSE Announcement dated on 12.02.2021)
Board Meeting - 06-Nov-2020 - -
Quarterly Results Outcome of the Board Meeting held on 13.11.2020 (As Per BSE Announcement dated on 13.11.2020) Unaudited Financial Results for the quarter and half year ended 30.09.2020 (As Per BSE Announcement Dated 14.11.2020)
Board Meeting - 07-Sep-2020 - -
Quarterly Results Roxy Exports Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/09/2020 ,inter alia, to consider and approve un-audited financial result for the quarter ended 30 June 2020. (AS Per BSE Announcement Dated on 06.09.2020) Outcome of the Board Meeting pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) held on 15.09.2020 (As per BSE Announcement Dated on 15/9/2020)
Board Meeting - 17-Aug-2020 - -
Roxy Exports Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/08/2020 ,inter alia, to consider and approve 1.Considering the change of name of the Company. 2.Considering and approval of the Increase in authorized share capital of the Company. 3.Considering the amendment in Object Clause of Memorandum of Association. 4.Considering fund raising by issue of shares on a right basis. 5.Considering fund raising by issue of shares on a preferential basis or by way of qualified institutions placement up to INR 100 crores. 6. Approving and adopting, the directors report for the F.Y. 2019-20, and the notice of 31st Annual General Meeting of the Company. 7. fixing the day, date, time and venue of the 31st Annual General Meeting of the Company. 8. Appointment of a scrutinizer for conducting E-voting as well as Ballot Voting Process at the 31st Annual General Meeting of the Company. 9.Any other matter with the permission of the Chair. Roxy Exports Ltd has informed BSE regarding Outcome of Board Meeting held on August 20, 2020.(As Per BSE Announcement Dated on 8/20/2020 7:17:45 PM)
Open ZERO Brokerage Demat Account